N- (4-oxo-3,4-dihydroquinazolin-2-yl)butan amides as androgen receptor modulators

Details for Australian Patent Application No. 2006294835 (hide)

International Classifications

Event Publications

20 March 2008 PCT application entered the National Phase

PCT publication WO2007/038444 Priority application(s): WO2007/038444

28 January 2010 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

26 May 2011 Application Accepted

Published as AU-B-2006294835

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.